Your account is not claimed yet. You can sign up with ORCID to claim your account.

Tamas Masszi (Tamás Masszi)

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 3

Top Topics

Antiretroviral Therapy

Chronic Lymphocytic Leukemia

Hepatitis C Virus

Multiple Myeloma

Top Venues

Leukemia & lymphoma

Ideggyogyaszati szemle

Semmelweis Egyetem Doktori Iskola (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Semmelweis Egyetem Doktori Iskola

Hungary

PHD

Publications

Henrietta Janicsák, Tamas Masszi, Péter Reményi, Gabor S Ungvari, Gábor Gazdag
[Impact of the type of hematopoietic stem-cell transplant on quality of life and psychopathology]. Ideggyogyaszati szemle 76 (1-2) (2023)
Tara Cochrane, Alicia Enrico, Guillermo José Ruiz Argüelles, Evgueniy Hadjiev, Ewa Lech-Maranda, Tamas Masszi, Eugene A Nikitin, Tadeusz Robak, Robert Weinkove, Shang-Ju Wu, Kavita R Sail, John C Pesko, Madhavi Pai, Viktor Komlosi, Mary Ann Anderson
Impact of venetoclax monotherapy on the quality of life of patients with relapsed or refractory chronic lymphocytic leukemia: results from the phase 3b VENICE II trial. Leukemia & lymphoma (2021)
Katalin Piroska Kiss, Gergely Varga, Gábor Mikala, Katalin Balassa, Andras Bors, Petra Kovy, Nora Meggyesi, Andras Kozma, Otto Csacsovszki, Peter Remenyi, Istvan Valyi-Nagy, Attila Tordai, Tamas Masszi, Hajnalka Andrikovics
The adverse effect of FOPNL genomic variant is reversed by bortezomib-based treatment protocols in multiple myeloma. Leukemia & lymphoma 59 (3) (2017)